Zaneta Odrowaz insider trades
Open-market stock purchases and sales by Zaneta Odrowaz, Chief Business Officer at Attovia Therapeutics, Inc, from SEC Form 4 filings since Aug 4, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 4, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ATTO Attovia Therapeutics, Inc: other filings, last Aug 4, 2026